Sanofi reported stronger than expected third-quarter profit on Friday, boosted by demand for blockbuster asthma drug Dupixent ...

Pharmaceutical launches and increased demand for its blockbuster Dupixent drug lifted net sales by 7% in the third quarter.

In this role, Arora will define and drive the strategic vision for India in alignment with Sanofi's global strategy. He will ...

Sanofi has dropped its respiratory syncytial virus (RSV) vaccine for toddlers after the candidate underperformed in a phase 3 ...

Sanofi’s $1.7 billion rare disease bet from last year has delivered a phase 2 win. | Sanofi’s $1.7 billion rare disease bet ...

The MoU supports Saudi Vision 2030 and the National Transformation Program’s focus on localizing healthcare manufacturing ...

Sanofi on Friday reported third-quarter profit that beat forecasts, boosted by demand for blockbuster asthma drug Dupixent, ...

Sanofi posted strong Q3 results amid currency challenges; discover key pipeline updates and growth prospects for investors.

Sales of Sanofi’s COVID-19 and flu vaccines fell 17% in the third quarter amid declining vaccination rates and pricing ...

Sanofi India announces the appointment of Deepak Arora as its Managing Director. Arora will lead strategic initiatives, ...

Deepak Arora has been appointed as the new Managing Director of Sanofi India. He brings over 30 years of pharmaceutical and healthcare industry experience to the role.

The new MD will define the company’s India strategy in alignment with Sanofi’s global strategy, besides driving priorities to ...